NIH-funded research R01 grant

Using genetics to improve diagnosis of narcolepsy and sleep disorders.

Official title: Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders.

Funded at Brigham and Women's Hospital · NIH-11051238 · Data updated 2026-11-12

This study is working to make it easier and faster for people with narcolepsy and sleep-wake disorders to get the right diagnosis by using genetic tests that are affordable and can help everyone, no matter their background.

More Circadian Rhythm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 16, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$625,118
NIH project number5R01HG012810-03
Project IDNIH-11051238 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing symptoms of narcolepsy or circadian rhythm sleep-wake disorders, particularly those who have faced challenges in obtaining a timely diagnosis.

Less likely to help

Patients with sleep disorders that are not related to narcolepsy or circadian rhythm issues may not benefit from this research.

What this research studies

This research aims to enhance the accuracy and speed of diagnosing narcolepsy and circadian rhythm sleep-wake disorders by leveraging genetic risk predictions. It addresses the significant delays in diagnosis, which can average six years, by developing polygenic scores that are applicable across diverse ancestry groups. The approach focuses on making genetic testing more accessible and affordable compared to traditional diagnostic methods, which often require specialized clinics and extensive insurance coverage. By integrating these genetic predictors into clinical practice, the research seeks to reduce misdiagnosis and improve health equity.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accurate diagnoses for patients suffering from narcolepsy and circadian rhythm disorders, ultimately improving their treatment outcomes.

How similar studies have gone: Previous research has shown promise in using genetic risk factors to improve diagnosis in various medical fields, suggesting that this approach could be effective for sleep disorders as well.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Lane, Jacqueline Marie — Brigham and Women's Hospital
  • Study coordinator: Lane, Jacqueline Marie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.